Therapy Areas: Allergy
ResVita Bio receives USD250,000 phase one Small Business Innovation Research grant from NIAID
19 September 2023 - ResVita Bio, a US-based synthetic biology startup, announced on Monday that it has received a USD250,000 Phase 1 Small Business Innovation Research (SBIR) grant from the National I...
The Access to Advanced Health Institute Receives USD 18m Award to Develop a Temperature Stable, Single-Dose Chikungunya RNA Vaccine Through a Phase 1 Clinical Trial
10 August 2023 - - US-based nonprofit biotech research institute The Access to Advanced Health Institute has received an USD 18m award from the National Institutes of Health to develop a temperature s...
Phase II Data of Oral Dexpramipexole Published in Eosinophilic Asthma
8 August 2023 - - Results from the Phase II EXHALE-1 study of dexpramipexole have been published online in the Journal of Allergy and Clinical Immunology, US-based Areteia Therapeutics, Inc said.
AllerVie Health Rebrands Southern Allergy & Asthma
13 June 2023 - - US-based allergy and immunology services provider AllerVie Health said that Southern Allergy & Asthma PC, originally acquired in 2021, will now fully transition to the AllerV...
Applied BioCode Inks Distribution Agreement with Medline Industries
...
Vedanta Biosciences Receives Fast Track Designation for VE303
9 May 2023 - - The US Food and Drug Administration granted Fast Track designation to US-based clinical-stage company Vedanta Biosciences' defined bacterial consortium candidate, VE303, for the pr...